{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:17:26Z","timestamp":1792045046594,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.jbspin.2004.08.011","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T20:34:57Z","timestamp":1103229297000},"page":"313-318","source":"Crossref","is-referenced-by-count":39,"title":["Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study"],"prefix":"10.1016","volume":"72","author":[{"given":"V\u00e9ronique","family":"Forin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Guigonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Filipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bensman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2004.08.011_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2004.08.011_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jbspin.2004.08.011_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","article-title":"Osteogenesis imperfecta Type VI: a form of brittle bone disease with a mineralization defect","volume":"17","author":"Glorieux","year":"2002","journal-title":"J Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2004.08.011_bib4","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V Osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2004.08.011_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2004.08.011_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2004.08.011_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1998.tb01388.x","article-title":"Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta","volume":"87","author":"Astr\u00f6m","year":"1998","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jbspin.2004.08.011_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","article-title":"Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta","volume":"16","author":"Devogelaer","year":"1987","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.jbspin.2004.08.011_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.08.011_bib10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.85.5.1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3\u00a0years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.08.011_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/JPEM.2002.15.2.163","article-title":"Pamidronate treatment of osteogenesis imperfecta-lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response","volume":"15","author":"Zacharin","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metabol."},{"key":"10.1016\/j.jbspin.2004.08.011_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bone.2003.11.019","article-title":"Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy","volume":"34","author":"Arikoski","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2004.08.011_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1297-319X(02)00434-7","article-title":"Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients","volume":"69","author":"Giraud","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2004.08.011_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s004310100844","article-title":"Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta","volume":"160","author":"Lee","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jbspin.2004.08.011_bib15","series-title":"Auxologie, m\u00e9thode et s\u00e9quences","author":"Semp\u00e9","year":"1979"},{"key":"10.1016\/j.jbspin.2004.08.011_bib16","series-title":"PEDI Research Group, Department of Rehabilitation Medicine, New England Medical Center Hospital, Boston, Version 1.0","author":"Haley","year":"1992"},{"key":"10.1016\/j.jbspin.2004.08.011_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jcem-70-5-1330","article-title":"Measurement of bone mineral content of the lumbar spine by dual energy X-Ray absorptiometry in normal children: correlation with growth parameters","volume":"70","author":"Glastre","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.08.011_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00003086-197306000-00024","article-title":"New approaches to treatment of osteogenesis imperfecta","volume":"93","author":"Castells","year":"1973","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.jbspin.2004.08.011_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2106\/00004623-196850010-00008","article-title":"Failure of anabolic steroids in the therapy of osteogenesis imperfecta: a clinical, metabolic and biochemical study","volume":"50","author":"Cattel","year":"1968","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.jbspin.2004.08.011_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1542\/peds.111.5.e601","article-title":"Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta","volume":"111","author":"Montpetit","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jbspin.2004.08.011_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized placebo-controlled trial","volume":"17","author":"Theriault","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbspin.2004.08.011_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMp038103","article-title":"Do bisphosphonates make children\u2019s bone better or brittle","volume":"349","author":"Marini","year":"2003","journal-title":"N. Engl. J. Med."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04002246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04002246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T01:52:37Z","timestamp":1548899557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X04002246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1297319X04002246"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2004.08.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}